Enyo Pharma
Develops small molecules drug candidates in infectious & metabolic diseases and oncology
2
Funding Rounds
$97.5m
Money raised
Overview
Develops small molecules drug candidates in infectious & metabolic diseases and oncology
-
Website:
- Business model: B2B
- Headquarters: Lyon
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Je Ga**** |
|
- | - |
| Pa An**** | - | - | - |
| Be de Ch |
|
- | - |
| La* Me | - | - | - |
| Ja*** Vo**** |
|
- | - |
| Vi Lo | - | - | - |
Funding series
Funding Series Analysis
The company Enyo Pharma has raised a total of $44m in funding over 2 rounds.
Key Insights:
- ENYO Pharma June 2018 Series B Funding Round: $44m
- ENYO Pharma funding round, June 2018: $53.5m
ENYO Pharma June 2018 Series B Funding Round
$44m
ENYO Pharma funding round, June 2018
$53.5m
Industries
Enyo Pharma is active in the following industries: